Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical trial NCT01847638 · COMPLETED
Trial details
- NCT number
- NCT01847638
- Sponsor
- Melissa Toyos
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-07-16
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.